SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 68 filers reported holding SYNERON MEDICAL LTD in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,103,000 | +1320.9% | 192,100 | +1272.1% | 0.01% | +1100.0% |
Q1 2017 | $148,000 | +25.4% | 14,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $118,000 | +18.0% | 14,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $100,000 | -7.4% | 14,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $108,000 | +5.9% | 14,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $102,000 | -5.6% | 14,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $108,000 | +8.0% | 14,000 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $100,000 | -32.9% | 14,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $149,000 | -13.9% | 14,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $173,000 | +32.1% | 14,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $131,000 | -6.4% | 14,000 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $140,000 | -2.8% | 14,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $144,000 | -17.2% | 14,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $174,000 | +1.2% | 14,000 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $172,000 | +42.1% | 14,000 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $121,000 | -0.8% | 14,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $122,000 | – | 14,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Senvest Management, LLC | 2,988,261 | $25,759,000 | 2.86% |
NORTH TIDE CAPITAL, LLC | 2,150,000 | $18,533,000 | 1.94% |
HOURGLASS CAPITAL, LLC | 838,900 | $7,231,000 | 1.26% |
Baupost Group | 4,000,000 | $34,480,000 | 0.98% |
DAFNA Capital Management LLC | 90,947 | $784,000 | 0.86% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 573,108 | $4,940,000 | 0.77% |
Visium Asset Management, LP | 3,405,000 | $29,351,000 | 0.67% |
PERRITT CAPITAL MANAGEMENT INC | 380,000 | $3,276,000 | 0.64% |
Leonard Capital Management, Inc. | 112,109 | $966,000 | 0.38% |
BRANDES INVESTMENT PARTNERS, LP | 1,765,018 | $15,214,000 | 0.20% |